Two independent studies have shown that reduction in kindlin-2 levels, either with siRNA that targets kindlin mRNA directly or by overexpression of miRNAs that reduce kindlin expression, sensitizes tumor cell lines to chemotherapeutic agents such as docetaxel75 and cisplatin77,91. The gene discussed is FERMT2; the disease is neoplasm.